Data / Form D filings / SyntheX,Inc.
SyntheX,Inc.: Form D filings
SyntheX,Inc., a biotechnology company in San Francisco, CA, filed 2 Form D notices with the SEC between 2017 and 2024. The latest, on January 11, 2024, reports $5.2 million sold of a $5.2 million offering to 10 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 409 Illinois Street, San Francisco, CA, 94158
- Phone
- (415) 706-8701
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1699260
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 11, 2024 | New notice | $5,175,000 | $5,175,000 | 10 | Dec 29, 2023 | sec.gov | |
| Mar 1, 2017 | New notice | $6,950,950 | $4,942,895 | $2,008,055 | 5 | Feb 17, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Charly Chahwan | Executive Officer, Director | |
| Maria Soloveychik | Executive Officer, Director | |
| Mohan Iyer | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Jan 8, 2024 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what SyntheX,Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.